Navigation Links
NanoViricides Drugs Found To Be Highly Effective Against Most,Recent Strain of the H5N1 Avian Flu Virus

ogenic influenza strains. It makes no difference to which type, subtype, or clade, they belong," said Anil R. Diwan, Ph.D., president of NanoViricides, Inc.

"We have shown that our drug candidates are the most effective drugs at present against even the newest subgroup of H5N1 viruses. Other companies continue to work on developing vaccines and drugs against the older Clade 1 H5N1 viruses, while we are working on the newest strains," said Eugene Seymour, MD, MPH, Chief Executive Officer of NanoViricides, Inc.

The Company plans to comment shortly on its in vitro/in vivo rabies studies.

About NanoViricides: http://www.nanoviricides.com

NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. Nanoviricides is currently developing drugs against Common influenza, Bird Flu H5N1, Rabies, Dengue and other viruses with various collaborators. The Company recently signed a Cooperative Research and Development Agreement with the Walter Reed Army Institute of Research (http://wrair-www.army.mil/) for creating new treatments for dengue fever using NanoViricides' virus-killing nanomedicine technology. This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors including the success of the Company's research and development strategy, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process.

Contact

NanoViricides, Inc.
Leo Ehrlich, 917-853-6440
leo@nanoviricides.com


'"/>




Page: 1 2

Related medicine technology :

1. Global Rabies Treatment May be Possible with NanoViricides Drugs
2. Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
5. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
6. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
7. Three New Drugs Mark New Era in Rheumatoid Arthritis Treatment
8. Major Manufacturer of Unapproved and Adulterated Drugs
9. Research Supported by Samuel Waxman Cancer Research Foundation Discovers Mode of Action of Arsenic-Based Drugs in Destroying Cancer Cells
10. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
11. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
Post Your Comments:
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces that a ... catalogue: North America Laparoscopes Market Outlook ... North America Laparoscopes Market Outlook to ... America Laparoscopes Market Outlook to 2020", provides key ... The report provides value, in millions of US ...
(Date:8/28/2014)... 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory and Reimbursement ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ) ... Reimbursement Landscape Poland " an essential source of ... healthcare market and provides insights into the demographic, ... the report provides valuable insights into the trends ...
(Date:8/28/2014)... China , Aug. 28, 2014 ... TPI ), a pharmaceutical company that specializes in ... generics and active pharmaceutical ingredients (API) today updates ... Company,s Qionglai Facility (QLF). The ... Practice (GMP) dataset for China Food & Drug ...
Breaking Medicine Technology:North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2
... Reportlinker.com announces that a new market research ... Patient Self-Monitoring: Devices, Markets, Players ... http://www.reportlinker.com/p0581171/Patient-Self-Monitoring-Devices-Markets-Players-and-Prospects .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic The ... serum levels is deemed to be a ...
... A new patent covering tumor suppression technologies, including the ... awarded to The University of Texas System ... to the discovery that chromosome 3p21.3 genes act as ... also known as FUS1, the anti-cancer agent in ...
Cached Medicine Technology:Patient Self-Monitoring: Devices, Markets, Players and Prospects 2Patient Self-Monitoring: Devices, Markets, Players and Prospects 3Genprex Announces New Patent Issuance in Japan 2
(Date:8/28/2014)... Wilmington, DE (PRWEB) August 28, 2014 Blood's ... murder, gunplay, sex, money and family ties in the heart ... like no other – a story about how disrespect caused ... and limbs on many streets. , The Yayo Boyz and ... leave news reporters speechless and local onlookers in a silent ...
(Date:8/28/2014)... Arizona State University graduate student Anthony Gonzales, co-founder ... one of five finalists in Entrepreneur magazine’s 2014 College ... fourth consecutive year that an ASU student has been ... SafeSIPP, and JJ Tang, co-founder of Vantage Realized, were ... dominated the competition: Three of the five finalists were ...
(Date:8/28/2014)... -- Arguments between parents may damage their relationships with ... more than 200 families were asked to make daily ... each day, mothers and fathers rated the quality of ... On days when parents reported conflict and tension in ... strained, according to the study recently published in the ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 ABC television ... the 49th MDA Show of Strength Telethon airing Sunday, ... country to help raise funds and awareness to help ... affected by muscle disease. , Viewers tuning into the ... enjoy heart-felt appeals and introductions from some of the ...
(Date:8/28/2014)... Governor of Yucatán, Rolando Zapata Bello, presented the ... event is organized by the Microcredit Summit Campaign in ... Microenterprise Financing Program ( PRONAFIM ) and will take ... Convention Center Yucatan Siglo XXI in the city of ... to host the 17th Microcredit Summit logistically but especially ...
Breaking Medicine News(10 mins):Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 2Health News:Arizona State University Grad Student in the Running for College Entrepreneur of the Year 3Health News:Parents' Fights May Strain Bonds With Their Kids 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 3Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 4Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 3
... Cannabis was well-tolerated, effective when added to existing ... News) -- Medicinal marijuana helps relieve neuropathic pain ... California, San Diego, School of Medicine study. , ... that wasn,t adequately controlled by opiates or other ...
... ... PALM BEACH, Fla., Aug. 6 The Breakers Palm ... but a company,deeply committed to each employee,s personal well-being. The ... the best of Florida,s,growing season exclusively for The Breakers, 2,300 ...
... Aduromed Begins Next Step in Corporate Evolution, Restructuring the Company ... and Augmenting its Board and Management Team, ... Board: ADRM) a leading manufacturer of medical waste,treatment systems, today ... raise of $3.8 million of new equity capital. As,part of ...
... PLC Systems Inc.,(Amex: PLC ), a company focused ... financial results for the three,and six month periods ended ... were $1,310,000 compared with,$1,932,000 in the second quarter of ... was $671,000, or $0.02 per diluted share, compared to ...
... - Mylan Increases Adjusted EPS Guidance for 2008 to $0.47 ... ... MYL ),today announced its financial results for the three and six months ended,June ... the three months ended June 30,2008, which excludes the impact of certain purchase ...
... ... Second Quarter 2008 Highlights:, ... of $27.4 million, up 86.3% over second quarter 2007,- Gross margin of 25.0%, up from 21.1% in the ... in the first quarter of 2008, - Operating ...
Cached Medicine News:Health News:Medicinal Marijuana Eases Neuropathic Pain in HIV 2Health News:Luxury Resort Operates Seasonal Green Market for 2,300 Staff 2Health News:Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital 2Health News:Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital 3Health News:PLC Systems Reports Second Quarter 2008 Results 2Health News:PLC Systems Reports Second Quarter 2008 Results 3Health News:PLC Systems Reports Second Quarter 2008 Results 4Health News:PLC Systems Reports Second Quarter 2008 Results 5Health News:PLC Systems Reports Second Quarter 2008 Results 6Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 2Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 3Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 4Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 5Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 6Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 7Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 8Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 9Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 10Health News:Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008 11Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 2Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 3Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 4Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 5Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 6Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 7Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 8Health News:Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million 9